- Home
- MPB vs AXGN Comparison
MPB vs AXGN Comparison
Compare MPB & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPB
- AXGN
- Stock Information
- Founded
- MPB 1868
- AXGN N/A
- Country
- MPB United States
- AXGN United States
- Employees
- MPB N/A
- AXGN N/A
- Industry
- MPB Major Banks
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MPB Finance
- AXGN Health Care
- Exchange
- MPB Nasdaq
- AXGN Nasdaq
- Market Cap
- MPB 634.9M
- AXGN 538.3M
- IPO Year
- MPB N/A
- AXGN N/A
- Fundamental
- Price
- MPB $30.22
- AXGN $10.93
- Analyst Decision
- MPB Buy
- AXGN Strong Buy
- Analyst Count
- MPB 2
- AXGN 6
- Target Price
- MPB $36.00
- AXGN $23.83
- AVG Volume (30 Days)
- MPB 99.3K
- AXGN 683.5K
- Earning Date
- MPB 07-23-2025
- AXGN 08-07-2025
- Dividend Yield
- MPB 2.65%
- AXGN N/A
- EPS Growth
- MPB 23.94
- AXGN N/A
- EPS
- MPB 2.88
- AXGN N/A
- Revenue
- MPB $181,865,000.00
- AXGN $194,520,000.00
- Revenue This Year
- MPB $24.31
- AXGN $18.08
- Revenue Next Year
- MPB $13.74
- AXGN $16.15
- P/E Ratio
- MPB $10.50
- AXGN N/A
- Revenue Growth
- MPB 9.21
- AXGN 18.81
- 52 Week Low
- MPB $21.11
- AXGN $7.23
- 52 Week High
- MPB $33.87
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- MPB 75.03
- AXGN 53.36
- Support Level
- MPB $28.02
- AXGN $9.35
- Resistance Level
- MPB $28.48
- AXGN $11.19
- Average True Range (ATR)
- MPB 0.60
- AXGN 0.46
- MACD
- MPB 0.33
- AXGN 0.28
- Stochastic Oscillator
- MPB 100.00
- AXGN 94.67
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.